Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-06-03Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-05-26Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBSGastrointestinal Endoscopy · 2026-04-306. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-EfficacyBiological Psychiatry · 2026-04-24Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-02Calcium activation mechanism of a noncanonical aromatic L-amino acid decarboxylase from psilocybin mushroom Psilocybe cubensisCommunications Biology · 2026-02-25Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescenceNeuropsychopharmacology · 2026-02-17An open-label pilot study of psilocybin-assisted therapy for binge eating disorderJournal of Eating Disorders · 2026-01-02Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measuresJournal of Psychopharmacology · 2025-12-31The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin ExperienceJournal of Clinical Psychopharmacology · 2025-12-08Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyBMJ Supportive & Palliative Care · 2025-11-02Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionGeneral Hospital Psychiatry · 2025-10-10Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-09-30“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-24Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-14Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case ReportPsychoactives · 2025-06-30Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot studyJournal of Affective Disorders · 2025-06-08Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J micePsychopharmacology · 2025-05-15The Rise of Psilocybin Use in the United States: A Multisource Observational StudyAnnals of Internal Medicine · 2025-04-20Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical TrialAmerican Journal of Psychiatry · 2024-12-31Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use DisorderPsychedelic Medicine · 2024-11-24Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trialJournal of Vision · 2024-11-04Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancerNature Mental Health · 2024-10-06Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot studyJournal of Affective Disorders · 2024-09-26Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorderPsychedelics. · 2024-09-23Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13SPONTANEOUS CHANGES IN CIGARETTE SMOKING FOLLOWING PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL USE DISORDERDrug and Alcohol Dependence · 2024-06-30High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-06-30Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse IndicationsDrug and Alcohol Dependence · 2024-06-30Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-AACS Chemical Neuroscience · 2024-06-24A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in AustraliaAddiction · 2024-05-20The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.govDrug Design Development and Therapy · 2024-03-31Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot studyScientific Reports · 2024-02-06Neural effects of psilocybin-treatment in patients with treatment-resistant depressionNeuroscience Applied · 2023-12-31Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisCancer · 2023-12-17Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.Psychology of Addictive Behaviors · 2023-06-04Cardiac Arrest Associated With Psilocybin Use and Hereditary HemochromatosisCureus · 2023-05-06Psilocybin-Based Breakthroughs in Natural MedicineCase Reports and Reviews · 2023-04-29Psilocybin-based mushrooms and usageCase Reports and Reviews · 2023-04-29347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic DisorderBiological Psychiatry · 2023-04-09Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorderJournal of Psychiatric Research · 2023-03-27Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS Pharmacology & Translational Science · 2022-11-01Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary Clinical Trials · 2022-11-01Use of psychedelics in the Czech Republic: results of recent population surveys.Central European Journal of Public Health · 2022-08-31To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.Experimental and Clinical Psychopharmacology · 2022-08-31Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.ACS Omega · 2022-07-04Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18Receptor binding profiles and behavioral effects of psilocybin analogsThe FASEB Journal · 2022-04-30Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience Applied · 2022-03-06P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-11-30Psychedelics, Sociality, and Human Evolution.Frontiers in Psychology · 2021-09-28Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-08-31Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.Experimental and Clinical Psychopharmacology · 2021-06-06Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved]Faculty of 1000 Research Ltd · 2020-12-31Psilocybin im Dorsch Lexikon der PsychologieUnknown journal · 2020-12-31The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionFrontiers in Pharmacology · 2020-12-02The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-02P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlapHuman Brain Mapping · 2020-08-20Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreatScientific Reports · 2019-10-23Psilocybin for depression: Considerations for clinical trial designJournal of Psychedelic Studies · 2019-08-31Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effectsNeuroImage · 2019-04-05Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom.ACS Chemical Biology · 2018-12-09T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking SmokersBiological Psychiatry · 2018-04-08Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.Frontiers in Pharmacology · 2018-04-02The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.Frontiers in Pharmacology · 2018-02-20Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.Frontiers in Pharmacology · 2018-02-19Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-01-04Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07The relationships of classic psychedelic use with criminal behavior in the United States adult population.Journal of Psychopharmacology · 2017-10-16Effect of Psilocybin on Empathy and Moral Decision-Making.The International Journal of Neuropsychopharmacology · 2017-08-31Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.Scientific Reports · 2017-04-18Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of Psychopharmacology · 2016-11-30Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of AlcoholismJournal of Humanistic Psychology · 2016-10-15Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG studyEuropean Neuropsychopharmacology · 2016-09-30[Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013].Das Gesundheitswesen · 2016-06-13Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.Behavioural Pharmacology · 2016-05-31PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe International Journal of Neuropsychopharmacology · 2016-05-26PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGThe International Journal of Neuropsychopharmacology · 2016-05-26PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGUnknown journal · 2016-05-26Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The Lancet Psychiatry · 2016-05-16Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.Psychopharmacology · 2015-07-31Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.Journal of Psychopharmacology · 2015-01-12Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.Journal of Neuroscience · 2013-05-31Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual HallucinationsOpen MIND · 2012-12-31Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.Journal of Psychoactive Drugs · 2012-10-31The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09Prediction of psilocybin response in healthy volunteers.PLoS ONE · 2012-02-16Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Neuropsychopharmacology · 2011-09-27The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.Biological Psychiatry · 2010-12-02Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.Journal of Psychopharmacology · 2010-09-19Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humansInternational Journal of Psychophysiology · 2008-07-16Values and beliefs of psychedelic drug users: a cross-cultural study.Journal of Psychoactive Drugs · 2006-05-31Identifying the presence of ‘magic mushrooms’ by DNA profilingScience & Justice · 2001-12-31